Article at a glance:

Pharma's emerging opportunity

Generally low income levels in emerging markets limit their consumption of pharmaceuticals. But affluent customers in these countries spend at least as much on health care as do people in the developed world—an interesting challenge for drugmakers.

The take-away

Pharma companies can tap into profitable customer segments in emerging markets by partnering with insurers or focusing on specific opportunities.

Note: This brief article, an explanatory paragraph commenting on a chart that describes a moment in time in an industry, is a Snapshot from our print edition.